O T C
PAOG Target CBD Pharma Development In Puerto Rico Could Get Boost From COVID-19

Sandusky, OH – Sep 17, 2020 – OTC PR WIRE — PAO Group, Inc. (OTC PINK: PAOG) today highlighted recent increased interest in the resurgence of industry-wide Pharmaceutical research and manufacturing in Puerto Rico. PAOG is currently in discussions in to engage a Contract Research Organization (CRO) in Puerto Rico to advance an Investigational New

PAOG Announces Agreement To Build Pharmaceutical Hemp Cultivar Facility On PURA Farmersville Site

Sandusky, OH – September 16, 2020 – OTC PR WIRE — PAO Group, Inc. (OTC PINK: PAOG) today announced an agreement with Puration, Inc. (OTC PINK: PURA) to build a proprietary hemp cultivar development facility on PURA’s Farmersville, Texas branded site.    PAOG recently acquired a hemp cultivation business from PURA and is now expanding

PAOG Advances RespRx Research Into International CBD Pharma Research Arena

Sandusky, OH – Sep 15, 2020 – OTC PR WIRE — PAO Group, Inc. (OTC PINK: PAOG) today announced an international research initiative to advance its hemp-derived cannabidiol (CBD) pharmaceutical treatment for Chronic Obstructive Pulmonary Disease (COPD). The COPD treatment, RespRx, is derived from a patented cannabis extraction method – U.S. Patent No. 9,199,960 entitled

PAOG Goes Global With CBD Pharmaceutical Research To Target $5.8 Billion Market

Sandusky, OH – Sep 15, 2020 – OTC PR WIRE — PAO Group, Inc. (OTC PINK: PAOG) Announces a multifold, international research initiative to advance its hemp-derived cannabidiol (CBD) pharmaceutical treatment for Chronic Obstructive Pulmonary Disease (COPD). The COPD treatment, RespRx, is derived from a patented cannabis extraction method – U.S. Patent No. 9,199,960 entitled

PAOG New Updates Toward Penetrating $5.8B Cannabis Pharmaceutical Market Coming This Friday

Sandusky, OH – Sep 14, 2020 – OTC PR WIRE — PAO Group, Inc. (OTC PINK: PAOG) today announced an interview of CEO James C. DiPrima on MoneyTV with Donald Baillargeon scheduled for release this Friday, September 18, 2020.  DiPrima will discuss the company’s latest CBD bio pharma developments in addition to fielding questions on

PAOG Rated Bullish And Given PPS Target In Updated Analyst Report Published Today

Sandusky, OH – September 8, 2020 – OTC PR WIRE — PAO Group, Inc. (OTC PINK: PAOG) today announced Goldman Small Cap Research has published an analyst research report update.  PAOG has recently entered the cannabis biopharmaceutical sector through two recent acquisitions.  The company acquired a cannabis cultivation business from Puration, Inc. (PURA). From Kali-Extracts

PAOG Announces Goldman Small Cap Research Update Scheduled Next Week

Sandusky, OH – September 2, 2020 – OTC PR WIRE — PAO Group, Inc. (OTC PINK: PAOG) today announced an analyst research report update form Goldman Small Cap Research scheduled to be published next week on Tuesday, September 8, 2020. The original Goldman Small Cap Research Update can be reviewed at: Under The Radar CBD

PAOG Files Q1 2020 and Q2 2020 Reports Moving Closer To Current Info Status

Sandusky, OH – August 25, 2020 – OTC PR WIRE — PAO Group, Inc. (OTC PINK: PAOG) today announced filing its Q1 2020 and Q2 2020 reports after yesterday announcing the filing of its 2019 annual report. PAOG recently executed two acquisitions as part of an overall business revitalization strategy bringing the company into the

PAOG Financial Report Compliance Expected Soon Following Recent CBD Biotech Acquisitions

Sandusky, OH – August 21, 2020 – OTC PR WIRE — PAO Group, Inc. (OTC PINK: PAOG) confirmed today that the company expects to soon have its public disclosures in compliance with OTC Markets “Current Information” reporting standard.  The efforts underway are expected to see the company back in compliance no later than by the

PAOG Confirms Analyst Report Update Expected After Coming Financial Report

Sandusky, OH – August 14, 2020 – OTC PR WIRE — PAO Group, Inc. (OTC PINK: PAOG) after earlier today announcing the publication of an initial Goldman Small Cap Research Analyst Report, management now confirms a prompt second report coming from Goldman following PAOG’s soon to be filed up-to-date financial reports. PAOG recently executed two

Contact Us

  • 707-OTC-WIRE (707-682-9473)
  • cs@otcprwire.com

All Rights Reserved © 2019